Association of circulating serum free bioavailable and total vitamin D with cathelicidin levels among active TB patients and household contacts
Loading...
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Research Square
Abstract
The free hormone hypothesis postulates that the estimation of free circulating 25(OH)D may be a better
marker of vitamin D status and is of clinical importance compared to total vitamin D levels because it is
the fraction involved in biological activities. Studies have shown that cathelicidin inhibits the growth of
Mycobacterium Tuberculosis in a vitamin D-dependent manner and therefore adequate vitamin D is
required for its expression. The aim of the study was to determine the association between serum-free
and bioavailable and total vitamin D with LL-37 levels in ATB patients, LTBI and individuals with no TB
infection. This was a cross sectional study and free and bioavailable vitamin D and LL-37 levels were
measured. 95 specimens were further selected to estimate total vitamin D levels. The median free and
bioavailable vitamin D levels of study participants were 3.8 ng/mL. The median LL-37 levels were 318.8
ng/mL. The mean total vitamin D levels were 18.9 ng/mL. Significantly weak inverse associations were
found and vitamin D is involved in the regulation of LL-37 expression and low vitamin D levels can alter
this relationship.
Background
Vitamin D deficiency is a prominent risk factor for TB disease worldwide (1–5). Vitamin D can be
obtained in two forms, D2 is obtained through diet and D3 is obtained through skin biosynthesis (6). Its
main circulating active metabolite 1, 25(OH)D is involved in regulation of antimicrobial activity and
therefore important in TB therapy (7). So far, total vitamin D or 25(OH)D has been considered a better
index for determining vitamin D status due to its longer half-life (6, 8–11). However, the free hormone
hypothesis postulates that the estimation of free circulating 25(OH)D may be a better marker of vitamin
D status and is of clinical importance compared to total vitamin D levels because it is the fraction
involved in biological activities (10, 12–14). Bioavailable 25(OH)D is used to represent free vitamin D and
the 10–15% fraction is loosely bound to albumin (8, 15). About 85–90% of total 25(OH)D is bound to
VDBP and 10–15% is loosely bound to albumin and a small fraction remains unbound (13, 16). Free
25(OH)D is increased and readily available to cells when DBP levels are at low concentrations Previous
studies report that changes in DBP levels and 25(OH)D binding affinity can lead to higher levels of free
25(OH)D, even in the absence of total vitamin D levels (17, 18). According to the Endocrine Society, total
vitamin D status is classified into three groups: <20 ng/mL deficient, 21–29 ng/mL deficient, and > 30
ng/mL optimal; or sufficient amounts (19). In vitro and in vivo studies have shown that LL-37 inhibits the
growth of MTB in a vitamin D-dependent manner (20, 21). Accordingly, studies have reported that
adequate levels of 25(OH)D are required for expression of LL-37(22, 23). According to our systematic
review, six studies reported that vitamin D regulates LL-37 expression and that vitamin D deficiency alters
this function (24). Because the free fraction of vitamin D, which enters cells to cause biological effects,
has not been studied with the LL-37 molecule, we hypothesize that there is no relationship between free
and bioavailable vitamin D and total vitamin D with the LL-37 levels among the ATB patients, LTBI and
individuals with no TB infection. This study aimed to determine the association between serum-free and bioavailable and total vitamin D with LL-37 levels in ATB patients, LTBI and individuals with no TB
infection.
Description
Keywords
Circulating serum free bioavailable, Vitamin D, Cathelicidin levels, TB patients
Citation
Acen, E. L., Worodria, W., Kateete, D. P., Olum, R., Joloba, M. L., Akintola, A., ... & Andia, I. B. (2022). Association of circulating serum free bioavailable and total vitamin D with cathelicidin levels among active TB patients and household contacts. https://doi.org/10.21203/rs.3.rs-2291169/v1